Inventor · disambiguated record
Rolf Bohlmann
Also filed as: BOHLMANN ROLF
63 granted patents·22 pending applications·304 citations·filing 1988–2020
98Inventor score
Top patents by PatentIndex Score
85 records- 0188US5807899ATriphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 1996·Granted Sep 15, 1998·56 cites·14 claims
- 0285US4916144AN-substituted imidazoles as aromatase inhibitorsSCHERING AG·Filed 1989·Granted Apr 10, 1990·30 cites·13 claims
- 0383US8916557B2Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-aminesLücking Ulrich·Filed 2012·Granted Dec 23, 2014·4 cites·15 claims
- 0483US7202260B2VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridonesSCHERING AG·Filed 2004·Granted Apr 10, 2007·11 cites·14 claims
- 0579US9133171B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Sep 15, 2015·5 cites·13 claims
- 0679US6956031B211β-Substituted 19-nor-17-α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ringSCHERING AG·Filed 2003·Granted Oct 18, 2005·12 cites·17 claims
- 0776US7846917B218-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the sameBAYER SCHERING PHARMA AG·Filed 2007·Granted Dec 7, 2010·4 cites·20 claims
- 0875US9669034B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Jun 6, 2017·2 cites·12 claims
- 0975US9255100B2Substituted imidazopyridazinesKLAR ULRICH·Filed 2011·Granted Feb 9, 2016·3 cites·14 claims
- 1074US6271403B17α-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 2000·Granted Aug 7, 2001·7 cites·2 claims
- 1173US9877954B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2017·Granted Jan 30, 2018·1 cites·15 claims
- 1273US7906533B2Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 15, 2011·1 cites·22 claims
- 1373US6790842B111β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTSSCHERING AG·Filed 2000·Granted Sep 14, 2004·7 cites·15 claims
- 1473US5021434AN-substituted imidazoles, as well as their use in pharmaceutical agentsSCHERING AG·Filed 1989·Granted Jun 4, 1991·14 cites·17 claims
- 1570US9650340B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted May 16, 2017·1 cites·9 claims
- 1670US6878750B2Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 2002·Granted Apr 12, 2005·4 cites·105 claims
- 1769US9499492B24-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted Nov 22, 2016·1 cites·14 claims
- 1869US8623850B215, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivativeKLAR ULRICH·Filed 2008·Granted Jan 7, 2014·1 cites·23 claims
- 1969US7074829B2Antiestrogens, process for their production and their pharmaceutical useSCHERING AG·Filed 2003·Granted Jul 11, 2006·3 cites·16 claims
- 2068US7018994B217α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONSSCHERING AG·Filed 2002·Granted Mar 28, 2006·3 cites·28 claims
- 2168US5986115A7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 1999·Granted Nov 16, 1999·16 cites·11 claims
- 2267US9108926B2Disubstituted 5-fluoro-pyrimidinesLücking Ulrich·Filed 2012·Granted Aug 18, 2015·1 cites·11 claims
- 2366US9790189B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine groupBayer Pharma AG·Filed 2015·Granted Oct 17, 2017·1 cites·26 claims
- 2466US9199999B2Substituted imidazopyrazinesKLAR ULRICH·Filed 2011·Granted Dec 1, 2015·1 cites·5 claims
- 2565US9284317B2Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Mar 15, 2016·1 cites·10 claims
- 2665US9212184B26-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Dec 15, 2015·1 cites·10 claims
- 2764US8207150B217β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivativeKUHNKE JOACHIM·Filed 2008·Granted Jun 26, 2012·1 cites·10 claims
- 2864US6288051B17 α-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 α(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 1999·Granted Sep 11, 2001·17 cites·16 claims
- 2964US5866560A7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 1997·Granted Feb 2, 1999·14 cites·41 claims
- 3063US7361645B2Androgenic 7-substituted 11-halogen steroidsBAYER SCHERING PHARMA AG·Filed 2002·Granted Apr 22, 2008·2 cites·20 claims
- 3162US11311520B2Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitorsBayer Pharma AG·Filed 2020·Granted Apr 26, 2022·0 cites·7 claims
- 3260US6495607B2Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 1999·Granted Dec 17, 2002·14 cites·28 claims
- 3360US5045558AN-substituted imidazoles and their use in pharmaceutical agentsSCHERING AG·Filed 1989·Granted Sep 3, 1991·7 cites·17 claims
- 3456US2007135489A1Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridonesHUTH ANDREAS·Filed 2007·Application pending·0 cites
- 3556US2010311702A119-nor-steroid derivatives with a 15alpha, 16alpha-methylene group and a saturated 17, 17-spiro-lactone ring, use thereof, and medicaments containing said derivativesBAYER SCHERING PHARMA AKTEINGESELLSCHAFT·Filed 2008·Application pending·0 cites
- 3655US7902229B2Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 8, 2011·0 cites·17 claims
- 3755US6166075AAntiestrogens, process for their production and their pharmaceutical useSCHERING AG·Filed 1999·Granted Dec 26, 2000·10 cites·31 claims
- 3854US7262023B2Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereofBAYER SCHERING PHARMA AG·Filed 2003·Granted Aug 28, 2007·0 cites·10 claims
- 3954US4925834A3-methylene-4-androsten-17-ones, process for their production and pharmaceutical preparations containing themSCHERING AG·Filed 1988·Granted May 15, 1990·8 cites·17 claims
- 4053US7145015B2Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agentsSCHERING AG·Filed 2005·Granted Dec 5, 2006·0 cites·43 claims
- 4152US2007298456A1Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereofZORN LUDWIG·Filed 2007·Application pending·0 cites
- 4251US7538100B217α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparationsBAYER SCHERING PHARMA AG·Filed 2005·Granted May 26, 2009·0 cites·27 claims
- 4351US2009012321A1Process for preparing 17alpha-acetoxy-6-methylenepregn-4-ene-3,20-dione, medroxyprogesterone acetate and megestrol acetateANNEN KLAUS·Filed 2008·Application pending·0 cites
- 4451US2019350910A1Substituted dihydroimidazopyridinediones as mknk1 and mknk2 inhibitorsBayer Pharma AG·Filed 2018·Application pending·0 cites
- 4550US8937058B217-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivativeKLAR ULRICH·Filed 2008·Granted Jan 20, 2015·0 cites·11 claims
- 4650US2011130371A1C-ring-substituted pregn-4-ene-21,17-carbolactones, and pharmaceutical preparations comprising the sameBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 4750US2011009654A111b-fluoro-3-acetoxyestra-3,5-dien-17-one and method for the production thereofPETROV ORLIN·Filed 2008·Application pending·0 cites
- 4849US9034856B217-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivativeKLAR ULRICH·Filed 2008·Granted May 19, 2015·0 cites·9 claims
- 4949US8987239B219-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivativesBAYER IP GMBH·Filed 2013·Granted Mar 24, 2015·0 cites·9 claims
- 5049US5502046A11β-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agentsSCHERING AG·Filed 1992·Granted Mar 26, 1996·8 cites·17 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Rolf Bohlmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →